Articles
The opportunity for India in the global biosimilars market

The opportunity for India in the global biosimilars market

As big pharma eyes the growing market for biosimilars in the West, Syamala Ariyanchira asks whether the traditional Indian generics giants can compete in this space. Dr. Reddy’s Laboratories (DRL) of India launched its first biosimilar product, Grafeel (filgrastim), in 2001 in India...

Articles
Healthcare Social Media Europe: the first 100 questions

Healthcare Social Media Europe: the first 100 questions

As healthcare social media groups come to life, Andrew Spong discusses the value of Twitter in supporting them and the rise of ‘Healthcare Social Media Europe’, or #hcsmeu. As Silja Chouquet and myself perched expectantly in front of our respective computers in Switzerland and the UK at noon…

Articles
An insight into generic patent strategies

An insight into generic patent strategies

In the first of a series of interviews we will be featuring on pharmaphorum, Paul Tunnah spoke with Pam Politis to talk about generic patent strategies. pharmaphorum caught up with Pam Politis, Senior Patent Attorney for Endo Pharmaceuticals in the US...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more